Nasdaq-listed Bicycle Therapeutics, a UK-headquartered pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, has entered into a securities purchase agreement…
UK: Bicycle Therapeutics raises US$555m via PIPE
…
…






